Matthieu Chasseray

Real-world Study of Avelumab First-line Maintenance Treatment in Patients with Advanced Urothelial Carcinoma in France: Overall Results from the Noninterventional AVENANCE Study and Analysis of Outcomes by Second-line Treatment

Philippe Barthélémy, Constance Thibault, Aude Fléchon et al. · European Urology Oncology · 2024 · 28 citations · Full text

Medicine, Oncology, Pharmacotherapy +4

Updated results from AVENANCE: Real-world effectiveness of avelumab first-line maintenance (1LM) in patients (pts) with advanced urothelial carcinoma (aUC) and analysis of subsequent treatment.

Philippe Barthélémy, Yohann Loriot, Constance Thibault et al. · Journal of Clinical Oncology · 2024 · 21 citations

Medicine, Oncology, Urology +10

Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with ¹²⁵I low dose rate brachytherapy for localized prostate cancer

Matthieu Chasseray, Gurvan Dissaux, Vincent Bourbonne et al. · Acta Oncologica · 2019 · 16 citations · Full text

Medicine, Radiation Oncology, Urology +17

Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).

Philippe Barthélémy, Yohann Loriot, Éric Voog et al. · Journal of Clinical Oncology · 2023 · 15 citations

Medicine, Oncology, Pharmacotherapy +14